![](https://agilis.nz/wp-content/uploads/2024/08/UBAC-2.jpg)
UBAC
UBAC is New Zealand’s second Mastitis vaccine (after our other Mastitis vaccine, Startvac) which aids in the prevention if clinical mastitis associated with gram positive bacteria
UBAC is New Zealand’s second Mastitis vaccine (after our other Mastitis vaccine, Startvac) which aids in the prevention if clinical mastitis associated with gram positive bacteria,
Active substances: Lipoteichoic acid (LTA) from Biofilm Adhesion Component (BAC) of Streptococcus uberis, strain 5616 ≥ 1 RPU* *Relative Potency Units (ELISA). Adjuvant (HIPRAMUNE U)
Subunit vaccine in emulsion for injection that aids in the prevention of clinical mastitis associated with gram positive bacteria in lactating dairy cows. UBAC should be considered as a component of a comprehensive mastitis management programme which includes other critical practices e.g. nutrition, hygiene practices (e.g. calving in clean dry areas, careful pre-milking hygiene, post milking teat sanitisers), dry-off practices (e.g. administration of internal teat sealants, selective dry cow therapy), milking practices (e.g. good milking technique, milking machine maintenance)
Approved for use on Organic Farms by AsureQuality.
Packaging:
50ml (25 doses)
10ml (5 doses)
Special storage instructions;
Keep out of reach of children
Store and transport refrigerated and protect from light. Do not freeze.
Once opened use within 10 hours.
Dosage:
Administer one dose (2 ml) by deep intramuscular injection in the muscles of the anterior neck according to the following immunisation program:
• First dose approximately 4 weeks prior to drying off
• Second dose at the day of drying off
• Third dose at approximately 2 weeks post calving
The full immunisation programme should be repeated with each gestation.
Withholding period:
Zero days